Page last updated: 2024-09-05

organophosphonates and Myelodysplastic Syndromes

organophosphonates has been researched along with Myelodysplastic Syndromes in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Edelmann, A; Hofmann, J; Kühl, JS; Sauerbrei, A; Voigt, S1
Jain, P1
Feldman, EJ1
de Villiers, EM; Gröne, D; Husak, R; Orfanos, CE; Treudler, R; Zouboulis, ChC1
Basara, N; Kiehl, MG1

Reviews

1 review(s) available for organophosphonates and Myelodysplastic Syndromes

ArticleYear
Lenalidomide-induced acute liver failure.
    Blood transfusion = Trasfusione del sangue, 2009, Volume: 7, Issue:4

    Topics: Adenine; Aged, 80 and over; Antineoplastic Agents; Antiviral Agents; Hepatitis B, Chronic; Humans; Lenalidomide; Liver Failure, Acute; Male; Myelodysplastic Syndromes; Organophosphonates; Thalidomide

2009

Trials

1 trial(s) available for organophosphonates and Myelodysplastic Syndromes

ArticleYear
Cidofovir for cytomegalovirus-preemptive therapy in stem cell transplant recipients.
    Blood, 2001, Sep-01, Volume: 98, Issue:5

    Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Myelodysplastic Syndromes; Organophosphonates; Organophosphorus Compounds; Prospective Studies; Transplantation, Homologous; Treatment Failure; Viremia; Virus Activation

2001

Other Studies

3 other study(ies) available for organophosphonates and Myelodysplastic Syndromes

ArticleYear
Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation.
    Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:5

    Topics: Acyclovir; Adenoviridae; Adenovirus Infections, Human; Antibiotic Prophylaxis; Antiviral Agents; Child, Preschool; Cidofovir; Cytosine; DNA, Viral; Drug Resistance, Viral; Epstein-Barr Virus Infections; Female; Foscarnet; Hematopoietic Stem Cell Transplantation; Herpes Simplex; Herpes Zoster; Herpesvirus 1, Human; Herpesvirus 3, Human; Herpesvirus 4, Human; Humans; Immunocompromised Host; Meningoencephalitis; Mucositis; Myelodysplastic Syndromes; Organophosphonates; Rituximab; Viral Load

2016
Does therapy-related AML have a poor prognosis, independent of the cytogenetic/molecular determinants?
    Best practice & research. Clinical haematology, 2011, Volume: 24, Issue:4

    Topics: Adenine; Anthracyclines; Antineoplastic Agents; Biomarkers, Tumor; Cytarabine; Cytogenetics; Female; Germany; Humans; Leukemia, Myeloid, Acute; Middle Aged; Myelodysplastic Syndromes; Naphthalimides; Naphthyridines; Organophosphonates; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Thiazoles

2011
Intravenous cidofovir treatment for recalcitrant warts in the setting of a patient with myelodysplastic syndrome.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2006, Volume: 20, Issue:2

    Topics: Adult; Antiviral Agents; Cidofovir; Cytosine; Diagnosis, Differential; Female; Hand; Humans; Infusions, Intravenous; Myelodysplastic Syndromes; Organophosphonates; Skin Diseases; Warts

2006